Labiana Health has been growing earnings at an average annual rate of 36.9%, while the Pharmaceuticals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 5.3% per year. Labiana Health's return on equity is 53.7%, and it has net margins of 3.4%.
How Labiana Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BME:LAB Revenue, expenses and earnings (EUR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
76
3
34
0
30 Sep 25
74
2
33
0
30 Jun 25
72
1
30
0
31 Mar 25
70
1
29
0
31 Dec 24
67
0
29
0
30 Sep 24
67
0
29
0
30 Jun 24
66
-1
29
0
31 Mar 24
63
-3
29
0
31 Dec 23
60
-4
29
0
30 Sep 23
60
-7
31
0
30 Jun 23
60
-10
34
0
31 Mar 23
60
-9
31
0
31 Dec 22
61
-9
28
0
31 Dec 21
59
-2
27
0
31 Dec 20
60
1
29
0
31 Dec 19
51
1
24
0
31 Dec 18
45
1
24
0
Quality Earnings: LAB has a high level of non-cash earnings.
Growing Profit Margin: LAB's current net profit margins (3.4%) are higher than last year (0.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LAB has become profitable over the past 5 years, growing earnings by 36.9% per year.
Accelerating Growth: LAB's earnings growth over the past year (913.7%) exceeds its 5-year average (36.9% per year).
Earnings vs Industry: LAB earnings growth over the past year (913.7%) exceeded the Pharmaceuticals industry 15.3%.
Return on Equity
High ROE: Whilst LAB's Return on Equity (53.69%) is outstanding, this metric is skewed due to their high level of debt.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/10 02:12
End of Day Share Price
2026/07/10 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Labiana Health, S.A. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.